Robertson Michelle's Insider Trades & SAST Disclosures
Robertson Michelle's most recent trade in Geron Corp. was a trade of 656,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 18, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Robertson Michelle.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Geron Corp. | Michelle Robertson J. | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 656,000 | 656,000 | - | - | Stock Option (right to buy) | |
| Geron Corp. | Michelle Robertson J. | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 110,000 | 110,000 | - | - | Restricted Stock Units | |
| Verastem Inc | Michelle Robertson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Verastem Inc | Michelle Robertson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 8,333 | 8,333 (0%) | 0% | 0 | Common Stock | |
| Geron Corp. | Michelle Robertson | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 250,000 | 250,000 | - | - | Employee Stock Option (Right to Buy) | |
| Verastem Inc | Michelle Robertson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 5,291 | 5,291 | - | - | Stock Option (right to buy) | |
| Verastem Inc | Michelle Robertson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Mar 2024 | 5,291 | 0 | - | - | Stock Option (right to buy) | |
| Geron Corp. | Robertson Michelle | EVP, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 850,000 | 850,000 | - | - | Employee Stock Option (Right to Buy) | |
| Verastem Inc | Michelle Robertson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 62,500 | 62,500 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Michelle Robertson | EVP, CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 9.87 per share. | 11 May 2023 | 949 | 106,610 (0%) | 0% | 9.9 | 9,369 | Common Stock |
| Editas Medicine Inc | Michelle Robertson | EVP, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 94,500 | 94,500 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Michelle Robertson | EVP, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 31,500 | 107,743 (0%) | 0% | 0 | Common Stock | |
| Editas Medicine Inc | Michelle Robertson | EVP, CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 8.89 per share. | 02 Mar 2023 | 184 | 107,559 (0%) | 0% | 8.9 | 1,636 | Common Stock |
| Editas Medicine Inc | Michelle Robertson | EVP, CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 9.67 per share. | 13 Feb 2023 | 4,287 | 76,243 (0%) | 0% | 9.7 | 41,435 | Common Stock |
| Editas Medicine Inc | Michelle Robertson | EVP, CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 8.16 per share. | 10 Jan 2023 | 1,752 | 80,530 (0%) | 0% | 8.2 | 14,296 | Common Stock |
| Editas Medicine Inc | Michelle Robertson | EVP, CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 10.23 per share. | 05 Dec 2022 | 193 | 82,282 (0%) | 0% | 10.2 | 1,974 | Common Stock |
| Editas Medicine Inc | Michelle Robertson | EVP, CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 06 Sep 2022 | 192 | 82,475 (0%) | 0% | 15.0 | 2,882 | Common Stock |
| Editas Medicine Inc | Michelle Robertson | EVP, CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 11.54 per share. | 03 Jun 2022 | 1,527 | 82,667 (0%) | 0% | 11.5 | 17,617 | Common Stock |
| Verastem Inc | Michelle Robertson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 62,500 | 62,500 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Michelle Robertson | EVP, CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 17.33 per share. | 03 Mar 2022 | 767 | 84,194 (0%) | 0% | 17.3 | 13,290 | Common Stock |
| Editas Medicine Inc | Michelle Robertson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 25.70 per share. | 11 Jan 2022 | 1,744 | 31,462 (0%) | 0% | 25.7 | 44,821 | Common Stock |
| Editas Medicine Inc | Michelle Robertson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2021 | 4,471 | 33,206 (0%) | 0% | 0 | Common Stock | |
| Verastem Inc | Michelle Robertson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2021 | 63,493 | 63,493 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Michelle Robertson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.65 per share. | 09 Aug 2021 | 2,500 | 31,235 (0%) | 0% | 30.7 | 76,625 | Common Stock |
| Editas Medicine Inc | Michelle Robertson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2021 | 2,500 | 115,000 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Michelle Robertson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 09 Aug 2021 | 2,500 | 28,735 (0%) | 0% | 60 | 150,000 | Common Stock |
| Editas Medicine Inc | Michelle Robertson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2021 | 2,500 | 117,500 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Michelle Robertson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 28 Jun 2021 | 2,500 | 28,735 (0%) | 0% | 50 | 125,000 | Common Stock |
| Editas Medicine Inc | Michelle Robertson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.65 per share. | 28 Jun 2021 | 2,500 | 31,235 (0%) | 0% | 30.7 | 76,625 | Common Stock |
| Editas Medicine Inc | Michelle Robertson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 32,197 | 32,197 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Michelle Robertson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 10,303 | 28,735 (0%) | 0% | 0 | Common Stock | |
| Editas Medicine Inc | Michelle Robertson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 78.27 per share. | 12 Jan 2021 | 1,568 | 18,432 (0%) | 0% | 78.3 | 122,727 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges